HTW Berlin at BIO-Europe 2026

Nov 9–11, 2026 Cologne, Germany ~5.8k attendees Website

HTW Berlin takes part in 2 sessions at BIO-Europe 2026 in Cologne. Its role centres on regulatory strategy, where it opens the track and joins a look at regulatory sandboxes for novel therapeutics and technologies. That session is shared with the European Medicines Agency and CSL Behring.

OrganizationBIO-Europe 2026 Attendance
HTW Berlin
Berlin, Germany
htw-berlin.de
Academic & tech transfer
Public university of applied sciences in Berlin, offering international life science master's programmes that include regulatory affairs.
Panel
Tue Nov 10
14:00–14:45
Harnessing Regulatory Sandboxes to Drive Innovation in Novel Therapeutics & Technologies
How regulatory sandboxes, where regulators let new products be tested under adjusted rules, could support new therapies and health technologies in Europe.
with Innovative Health Initiative, European Medicines Agency, CSL Behring
Chair
Wed Nov 11
08:55–09:00
Chair’s Opening Remarks
Regulatory Strategy

Explore the full BIO-Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Cologne. Leave your work email and we’ll be in touch.

Privacy

Download the full BIO-Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from HTW Berlin

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by EBD Group, Informa Connect or BIO-Europe. Submit a correction